Page 129 - Read Online
P. 129

Nwabuobi et al.                                                                                                                                                                   Thymoma associated panencephalitis






               Improvement  Total remission of  symptoms 1 week after   thymomectomy  Some improvement of   speech and cognitive   function, but died 2   months later from mets  Had thymomectomy  several years prior to 3  separate presentations  with ELE, 1 of which did  not require treatment; the  other 2 responded fairly   well to steroids  Improved initially with  no treatment, but with   recurrence, partial  improvement of mental   status 2 months after   chemo  Withi









               Treatment  Thymomectomy  Steroids, IVIG,   1 cycle of   chemotherapy  Thymomectomy,   steroids  Thymomectomy,   chemotherapy  Thymomectomy,   radiation   therapy,   steroids, IVIG,   PLEX  Thymomectomy  Thymomectomy,   steroids, PLEX





              Cell surface vs.   onconeuronal Ab  -  Cell surface  Cell surface  Cell surface  Onconeuronal  Cell surface/  onconeuronal  Cell surface/  onconeuronal









               Antibodies (-)  AchR, Hu, Ri, Yo  “Rest of   paraneoplastic   profile, including   CRMP-5”  Hu, Ri, Yo,   CRMP5, Ma-2,   Tr, amphiphysin,   VGKC-complex  AchR, Hu, Yo  VGKC-complex  AchR  Hu, Ri, Yo, PCA-  2, amphiphysin,   VGKC-complex,   VGCC, neuronal   AchR GAD: glutamic acid decarboxylase; VGKC: voltage gated potassium channel; AchR: acetylcholine receptor; CRMP-5: collapsing response mediator protein 5; VGCC: voltage gated calcium  channel; NMDAR: N-m







               Antibodies (+)  -  AchR (binding,   modulating),   striational Ab,   VGKC-complex  AchR  GABA-A, Caspr2  GAD, neuropil of   hippocampus  Hu, VGKC-  complex  AchR (binding,   modulating),   striational Ab,   CRMP5











              Neurological   symptoms  Seizures, aphasia  MG; 4yrs later, seizure,   confusion, aphasia  Seizure; later,   incontinence,  confusion, decreased   verbal response,   apallial syndrome,   RLE weakness;   later, decreased   consciousness and   apallial syndrome  Memory impairment,   apathy  Seizure, confusion,  agitation; later, spasms   and rigidity  Vertigo, tinnitus,   vomiting; later,   leg weakness and   numbness, tingling of  toes and fingers, R visual






               Gender  F  F     F                F           M              F            M                    immunoglobulin; ELE: extralimbic encephalitis; MG: myasthenia gravis



               Age   55  43     33               59          38             34           55


               Year  2009  2009  2007            2006        2005           2002         2000




               Paper  Rizzardi  et al. [19]  Hammoud  et al. [20]  Okita  et al. [21]  Ohshita  et al. [22]  Ances  et al. [23]  Vernino  et al. [24]  Rickman  et al. [25]



                          Neuroimmunology and Neuroinflammation ¦ Volume 4 ¦ June 16, 2017                121
   124   125   126   127   128   129   130   131   132   133   134